NCT06888869Not yet recruiting
Interactive Home-based Rehabilitation Exercise Assessment Platform and Exploration of Clinical Effects in Patients with Parkinson's Disease
The Development and Verification of an Interactive Home-based Rehabilitation Exercise Assessment Platform and Exploration of Technology Acceptance and Clinical Effects in Patients with Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 26 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to develop an "Interactive Home-based Rehabilitation Exercise Assessment Platform" that incorporates visual feedback similar to virtual reality into rehabilitation machines and aerobic cycling programs. In the clinical research part, 92 Parkinson's disease patients will be randomly assigned to three groups: the clinical rehabilitation group, the home-based rehabilitation group, and the control group. Each group will undergo the intervention twice a week, with each session lasting about 30-45 minutes over a period of 12 weeks for a total of 24 combined resistance and aerobic rehabilitation training sessions. The effectiveness evaluation will include measurements of upper limb grip strength, lower limb muscle strength, the 3-meter sit-to-stand test, the 6-minute walk test, the Parkinson's Disease Severity Scale, the Quality of Life Scale, the 10-meter walk test, and technology acceptance forms.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- First submitted
- 17 Mar 2025
- Start date
- 21 Mar 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Diseases
- Parkinson disease
- NCT number
- NCT06888869
What you commit to
- Study type: Interventional
- Planned participants: 92
- From 21 Mar 2025 to the primary completion date, 31 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Rheumatic diseases
- Unstable heart and respiratory diseases (such as angina pectoris, pulmonary embolism, etc.)
- Severe or unstable neurological or orthopedic diseases (such as stroke, dementia, fractures, etc.)
- Severe hearing or visual impairment, unable to cooperate with researchers
- People diagnosed with mental illness
- People with a history of epilepsy or a direct blood relative with a history of epilepsy
- People with any uncontrolled chronic diseases that may cause safety concerns
Other
- Pregnant or breastfeeding women
- People living without family members or case caregivers.
Who the study is looking for
- Patients diagnosed with primary Parkinson's disease by a neurologist
- Modified Hoehn and Yahr Scale I-III
- Aged 45-85 years old
- Mini-Mental State Examination (MMSE) score of 24 or above
- Stable on Parkinson's disease-related medications
- Able to walk independently or use assistive devices to walk 15 meters
- Able to understand the movements and test items
- Able to understand and willing to sign the informed consent form
Age in the registry: 45 years to 85 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.